U.S. Volleyball Athlete Alexandra Klineman Accepts Finding of No Fault for Anti-Doping Rule Violation
8 November 2017
USADA announced today that Alexandra Klineman, of Manhattan Beach, Calif., an athlete in the sport of volleyball, has tested positive for prohibited substances, which were determined to have been ingested by her without fault or negligence.
Klineman, 27, tested positive for hydrochlorothiazide and triamterene as the result of an out-of-competition urine sample she provided on July 25, 2017. Hydrochlorothiazide and triamterene are both Specified Substances in the class of Diuretics and Masking Agents and prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the Fédération Internationale de Volleyball Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
During USADA’s investigation into the circumstances of her case, Klineman provided USADA with records for a permitted oral prescription medication she was taking at the time of her positive test. This permitted medication did not list hydrochlorothiazide and triamterene on the label, which are available only by prescription, or any other prohibited substances. However, detailed laboratory analyses subsequently conducted on the medication tablets confirmed hydrochlorothiazide and triamterene contamination.
As a result, Klineman will not face a period of ineligibility for her positive test, and because the sample was collected out-of-competition, there are no competitive results to disqualify. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and psychoactive drugs. In addition, USADA manages a drug reference hotline, Global Drug Reference Online (https://www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, including foreign athletes competing, training, or living in the U.S. USADA is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.